Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
Editorial Board
Editors-in-Chief
Helmut H. Popper
Department of Pathology, Medical University of Graz, Graz, Austria
Interests:

Pulmonary and mediastinal pathology

Special Issue and Columns in AccScience journals
Profile:

Retired Professor of the Medical University of Graz 
The former director of the Pathology Institute of the Medical University of Graz 
The founding chairperson of the Pulmonary Pathology Working Group of the European Society of Pathology (ESP) 
Core members of the Interstitial Lung Disease Classification Committee of the American Thoracic Society (ATS) / European Respiratory Society (ERS)

Mingzhu Yin
1. Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Detection and Treatment Center (CEDTC) and Translational Medicine Research Center (TMRC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China
2. Chongqing Technical Innovation Center for Quality Evaluation and Identification of Authentic Medicinal Herbs, Chongqing, China
3. School of Medicine, Chongqing University, Chongqing, China
4. Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
Interests:

Tumor immune regulation mechanism; Synergistic mechanism of tumor epigenetics and immunity 

Special Issue and Columns in AccScience journals
Profile:

Chief Physician, Professor and Doctoral Supervisor of Three Gorges Hospital, Chongqing University

Director of the Medical Pathology Center, Clinical Research Center, Early Diagnosis and Treatment Center for Tumors and Translational Medicine Research Center

Director of the Middle Line (NUT) Cancer Specialty


Clinical Focus: Early diagnosis and standardized treatment of tumors, including the establishment of the first national NUT midline carcinoma specialty and the creation of an integrated diagnosis and treatment platform for this disease. Research Focus: Anti-tumor clinical drug development and translational research; research on tumor immune regulation mechanisms; research on the synergistic mechanism of tumor epigenetics and immunity. Currently Responsible Projects: Obtained 5 clinical approval documents for national 1.1 class new drugs; led the formulation of 1 national expert consensus and participated in the formulation of 1 consensus; won the first prize of the China Industry-University-Research Cooperation Innovation Award (individual), the first prize of the China Invention Association's Entrepreneurship and Innovation Award (1/6), the first prize of the Ministry of Education's Scientific and Technological Progress Award (6/16), and the second prize of the provincial and ministerial scientific and technological progress award (6/8); applied for over 20 national invention patents and software copyrights, with 5 authorized; published over 110 SCI papers, including over 50 as first or corresponding author; research results published in Nature, Advanced Science, Science Translational Medicine, JCI, J Hepatol, Circulation Research, Nature Communication, etc.; led 1 sub-project of the National Key Research and Development Program and 2 National Natural Science Foundation of China general projects. Main Academic Appointments: President of the Digital Healthcare Committee of the China Food and Drug Safety Enterprise Quality Promotion Association (FDSA), Vice Chairman of the Integrated Lung Cancer Prevention and Screening Committee of the China Anti-Cancer Association, Chairman of the NUT Midline Carcinoma Gene Diagnosis Working Group of the Gene Diagnosis Committee of the China Anti-Cancer Association, Vice President of the Overseas Chinese Association of Science and Technology and the Liaison Officer of Chongqing.

Associate Editors
Jan B. Vermorken
Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium
Interests:

Gynecologic oncology; Head and neck oncology

Profile:

Emeritus Professor of Oncology, Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium

His main fields of interest are gynecologic oncology, and head and neck oncology. In addition, he co-ordinated large trials in breast and colon cancer. His main research areas concern early clinical and pharmacological studies with new drugs, studies on the interaction of chemotherapy and radiation therapy and HPV in various malignancies. He devotes a significant amount of time to teaching, professional training, and continuing medical education.

Professor Vermorken serves on the editorial board of six international journals, reviewer of 13 cancer journals and author or co-author of more than 500 publications. He is Editor-in-Chief of ONCO since 2007. As of January 1, 2009 he is Editor-in-Chief of Annals of Oncology, the official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology.

Zhimin Bian
National Cancer Center, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
Interests:

Palliative therapy; Cancer supportive therapy

Profile:

Associate Chief Physician of the Comprehensive Department of the Cancer Hospital of the Chinese Academy of Medical Sciences

Doctor of Oncological Surgery from Peking Union Medical College

Dr. Bian has been engaged in the clinical work of comprehensive treatment, palliative treatment and emergency treatment of abdominal tumors for a long time. In 2014, he was the first to carry out the implantation surgery of infusion port via the internal jugular vein in the hospital. Has published over 10 first-author papers, participated in the compilation of 3 books, participated in the translation of 1 book, and has undertaken several clinical research projects.

Shuangqi Cai
Pulmonary and Critical Care Medicine Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Interests:

Lung cancer

Paolo Caliceti
Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy
Interests:

Multifunctional polymeric bioconjugates; Tumor; Polymeric micelles; Supramolecular systems; Physical and chemical polymer bioconjugtion

Profile:

Paolo Caliceti is a member of Editorial Boards of multiple pharmaceutical journals and,  since 2018, he is serving as Associate Editor of the Journal of Controlled Release. He has been a member of national and international review panels for research projects, including the European Research Council and the Innovative Medicine Initiative, and as consultant with Italian and International pharmaceutical companies. 

His research activity is related to the synthesis, characterization and preclinical validation of targeted drug delivery systems to improve drug bioavailability, stability, local delivery, active and passive targeting, and controlled delivery. The activities of the Caliceti ‘s research groups are mostly centered around protein PEGylation; nano- and micro-particle development by supercritical techniques; stimuli sensitive and targeted polymer bioconjugates, gold nanoparticles, micelles, liposomes and polymersomes, supramolecular assemblies for protein and oligonucleotide delivery. 

Paolo Caliceti has co-authored over 180 papers and is the co-inventor of 17 patents.

Amancio Carnero Moya
Instituto de Biomedicina de Sevilla, Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n, Seville, Spain
Interests:

Identification of new genes involved in cancer; Its characterization and translation to clinic; Identification and validation of new targets for anticancer drug discovery

Profile:

Head of the Assay Development Group at the Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid

Leader of the Molecular Biology of Cancer Lab in Biomedical Institute of Seville (IBiS/CSIC)

Jinhai Deng
Kings College London, London, UK
Interests:

Research on the diagnostic biomarkers for early stage cancer and the development of immunotherapy

Emilio Hirsch
University of Turin, Turin, Italy
Interests:

Signal transduction; PI3K; Cancer; Heart failure; Inflammation

Profile:

Emilio Hirsch is Professor of Experimental Biology in the Medical School, University of Torino since 2005. He has authored more than 200 scientific publications that received more than 18000 citations. He is an internationally recognized scientist, elected member of the European Molecular Biology Organization (EMBO), Fellow of the International Society of Heart Research (ISHR) and receiver of the American Association for Cancer Research (AACR) innovator prize. He contributed seminal work in the
characterization of key signal transduction enzymes named PI3Ks with publications in Science, Nature and Cell. He was involved in the identification of the first PI3K inhibitors for the treatment of cancer and
inflammation. His experience in drug discovery was seminal to the design of Kither’s KITCL27. He discovered the scaffolding function of PI3Kgamma that led to the design of Kither’s KIT2014.

Evan T. Keller
Department of Urology and Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA
Interests:

Prostate cancer; Urology; Metastasis; Tumor microenvironment and spatial analysis

Oliver Kepp
Institut National de la Sante et de la Recherche Medicale, Centre de Recherche des Cordeliers, Paris, France
Interests:

Cancer; Immunology; Cell death; Apoptosis; Autophagy

Sung-hoon Kim
Department of Oriental Pathology, College of Oriental Medicine, Kyunghee University, Seoul, South Korea
Interests:

Beclin 1; Chloroquine; Cancer cell

Jesang Ko
Department of Life Sciences, Korea University, Seoul, South Korea
Interests:

Prostate cancer; α-Actinin-4; Leucine zipper protein; Colorectal cancer cells

Massimo Libra
Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
Interests:

Identification and characterization of gene and transcriptional signaling alterations involved in tumor development and progression, as well as on the validation of their diagnostic, prognostic and predictive significance

Tian-Jie Lyu
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Interests:

Glioma and functional outcome

Wenping Ma
Department of Neuropathology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Interests:

Cancer

Fabio Malavasi
University of Turin and Fondazione Ricerca Molinette, Torino, Italy
Interests:

CD38; Therapeutic antibodies; Tumor microenvironment; NAD metabolism

Kishor Pant
The Hormel Institute, University of Minnesota, Austin, TX, USA
Interests:

Hepatocellular carcinoma (HCC); Cholangiocarcinoma (CCA); Polycystic liver diseases (PLD); Primary cilia mediated regulation of the cell growth and cellular metabolism; Ciliotherapy and drug development that induce the inhibition of HDACs proteins, especially proteins that inhibit cilia formation in cancer and cystic liver cells

Athanasios Papavassiliou
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Interests:

Signal transduction in solid tumors; Transcription factors; Cancer mechanobiology

Profile:

Athanasios G. Papavassiliou is a Professor of Biochemistry and is Head of the Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Greece. He obtained his MD from the School of Medicine of the Aristotle University of Thessaloniki, Greece (1984) and his PhD from Columbia University, New York, USA (1989). He pursued postdoctoral training at the Department of Microbiology, College of Physicians & Surgeons of Columbia University and at the EMBL, Heidelberg, Germany (1989-1991), where he then served as Staff Scientist (faculty position; 1991-1996). He has published 549 original research and review articles in international peer-reviewed journals [2021 JCR® CIF: 5000 MIF: 9.277; h-index: 92; i10-index: 392; total citations: >28651]. He has been the recipient of numerous national and international research awards, among them the prestigious “ICAAC Young Investigator Award” for excellence in research in the broad areas of microbiology and infectious diseases (1990, American Society for Microbiology). He has also been awarded the degree of ‘Doctor Honoris Causa’ from the Faculty of Health Sciences-School of Medicine, University of Patras, Greece (2013). He is an Honorary Member from Abroad of the Romanian Academy of Medical Sciences (elected in 2022). His research interests focus on the study of signal transduction to transcription factors in cell differentiation, tumorigenesis (cancer mechanomedicine), and certain disease pathobiologies.

Silvia R Rogatto
Vejle Hospital, IRHR, University of Southern Denmark, Odense, Denmark
Interests:

Oncology; Human genetics; Molecular genetics; Oncogenetics; Cancer

Alfred Sze Lok Cheng
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
Interests:

Tumor immunology and immunotherapy; Epigenetics; Hepatocellular carcinoma

João T. Barata
Faculty of Medicine, University of Lisbon, Lisbon, Portugal
Interests:

T cell; Leukemia; PI3K/AKT/mTOR pathway; Protein kinase B; PTEN

Youtao Yu
Department of Intervention Therapy, The Fourth Medical Center of PLA General Hospital, Beijing, China
Interests:

Interventional ultrasound; Image-guided puncture; Image-guided interventional therapy; Peripheral vascular disease interventional therapy

Xin Zhao
Department of Anesthesiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China
Interests:

Anesthesia and neuropathic pain in children with tumor

Editorial Board Members
Ahmed Abu-Zaid
Department of Pharmacology,  College of Graduate Health Sciences,  University of Tennessee Health Science Center,  Memphis, TN, USA
Interests:

Molecular & systems pharmacology; Cancer/molecular biology; Diagnostics; Therapeutics; Systematic review and meta-analysis of RCTs in areas of general internal medicine, nutrition, pharmacology, therapeutics, and obstetrics and gynecology

Thomas Adrian
Department of Basic Medical Sciences, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
Interests:

Glucose metabolism; Insulin signaling; Metabolic endocrinology; Diabetes; Cancer biology

Aamir Ahmad
Hamad Medical Corporation, Doha, Qatar
Interests:

Epigenetics; Cancer; Non-coding RNAs; Inflammatory skin diseases; Precision medicine

Greta Alì
Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy
Interests:

Lung pathology; Mesothelial pathology; Molecular pathology

Michele Ammendola
Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy
Interests:

Surgical oncology; Tryptases; Angiogenesis; Tolonium chloride; Cancer

Zohreh Amoozgar
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Interests:

Drug delivery; Tumor immunology; Tumor biology

Hugo Arias-Pulido
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA
Interests:

Cancer biology; Genetics; Genomics; Cancer cell lines; Cancer biomarkers; Tumor models; Animal models; Patient-derived xenograft models; Vaccines; Breast cancer; Inflammatory breast cancer; Canine mammary tumors; Canine tumors

Nicolae Bacalbasa
"Dan Setlacec" Center of Gastrointestinal Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Interests:

Surgical oncology; Gynecologic oncology; Surgery; Transplantation

Natalia Baran
Department of Hematology and Hematological Central Laboratory, University of Bern, Bern, Switzerland
Interests:

Drug resistance in hematologic malignancies; Metabolic reprogramming in hematologic malignancies; MDS; Clonal hematopoiesis; CHIP; CCUS; Leukemia/macrophage function

Armand Bensussan
Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
Interests:

Immunology; Dermatology; Oncology; Skin neoplasms

Emilio Bertani
Division of Digestive Surgery, European Institute of Oncology IRCCS, Milan, Italy
Interests:

Oncology; Surgery; Laparoscopic surgery; Colorectal surgery; Cancer surgery

Profile:

He has conducted research that has resulted in publications in international journals in the field of minimally invasive laparoscopic and robotic surgery for colorectal cancer. He has also published research on the role of surgery in the multimodal treatment of gastroenteropancreatic neuroendocrine tumors. He is actively involved in national and international educational meetings as a lecturer, particularly due to his experience in the field of neuroendocrine tumors.

Prashanth Kumar Bhusetty Nagesh
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Interests:

Cancer biomarkers and therapeutics; Cancer immunology; Molecular bioimaging; Nanomedicine; Drugs screening for anti-cancer activity; Chemoresistance; Antibody development; Medical radiation countermeasures

Paolo Boffano
Division of Dentistry, Vercelli Hospital, Vercelli, Italy
Interests:

Maxillofacial trauma; Oral cancer; Head and neck cancer; Oral surgery

Roberta Bortolozzi
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
Interests:

Cancer biology; Apoptosis; Cancer cell line

Steven Brower
1. The Lefcourt Family Cancer Treatment and Wellness Center, Englewood Health, Englewood, NJ, USA
2. Icahn School of Medicine at Mount Sinai, New York, NY, USA
3. Hackensack Meridian School of Medicine, Nutley, NJ, USA
Interests:

Pancreatic cancer; Gastric cancer; GI neuroendocrine cancer; Minimally invasive surgical approaches for cancer; Molecular genetics of GI malignancies; Surgical treatment of colorectal liver metastases; Quality issues in surgical oncology

Special Issue and Columns in AccScience journals
Profile:

Dr. Steven Brower is a faculty member at Hackensack Meridian School of Medicine, Nutley, New Jersey, USA. He is a surgical oncologist with extensive clinical and research experience in gastrointestinal and hepatobiliary cancers. Dr. Brower has contributed to numerous academic publications and is actively involved in cancer education, clinical trials, and multidisciplinary care initiatives.

Jian Cao
Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
Interests:

Cancer epigenetics; Cancer immunology; Histone modification; Chromatin remodeling

Darren R Carpizo
Division of Surgical Oncology, University of Rochester Medical Center, Rochester, NY, USA
Interests:

Pancreas cancer; P53; Mutant p53; Liver cancer; Cancer dormancy

Fabrizio Carta
Pharmaceutical and Nutraceutical Section, University of Florence, Florence, Italy
Interests:

Hypoxic cancers; Medicinal chemistry; Drug design

Thangavel Chellappagounder
Department of Medicine, Center for Translational Medicine, Thomas Jefferson University. Philadelphia, PA, USA
Interests:

Tumor immunology; Cell cycle; Retinoblastoma protein and cancer; Prostate cancer; Breast cancer; Lung cancer

Profile:

A translational cancer biologist with more than 40 publications in high-tier journals. The work mainly focuses on mitigating prostate, breast and lung cancers by rewiring the tumor suppressor RB via small molecular inhibitors and ionizing radiation.

Yongqiang Chen
Paul Albrechtsen Research Institute, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada
Interests:

Autophagy; Cell death; Cancer; Signaling pathway; Microbiology

Min Soon Cho
Department of Pulmonary Medicine, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interests:

Cell proliferation; Cancer cells; Tumors; Cancer research

Lili Cui
Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China
Interests:

Stem cell therapy

David Danielpour
Division of General Medical Sciences-Oncology, Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
Interests:

TGF-beta; Prostate cancer; Androgen; Akt; mTOR; bmp; Hic-5; Renal cancer; Hypoxia

Undurti Narasimha Das
UND Life Sciences, Battle Ground, WA, USA
Interests:

Polyunsaturated fatty acids; Cytokines; Free radicals; Eicosanoids; Diabetes mellitus; Cancer; Rheumatology; Sepsis

Efstathios Detorakis
Department of Ophthalmology, University Hospital of Heraklion, Crete, Greece
Interests:

Autografts; Eye neoplasms; Fibrin glue; Glaucoma drainage implants; Hyphema; Pterygium; Trabeculectomy; Uvea melanoma

Arun Dharmarajan
1. Faculty of Clinical Research, Sri Ramachandra Institute of Higher Education and Research, Chennai, India
2. Professor Emeritus, School of Human Sciences, The University of Western Australia, Perth, Australia
3. Adjunct Professor, Curtin Medical School, Curtin University, Perth, Australia
Interests:

Cancer; Wnt signalling; Secreted frizzled related protein-4; Cancer stem cells; Angiogenesis; ROS signalling

Jennifer A. Doll
School of Biomedical Sciences & Health Care Administration, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Interests:

Cancer biology; Prostate cancer; Obesity and dietary fats in prostate cancer; Angiogenesis

Nejat Düzgüneş
Professor, Department of Biomedical Sciences, Arthur A Dugoni School of Dentistry, University of the Pacific, San Francisco, CA, USA
Interests:

Phage therapy of mycobacterial infections; Photodynamic therapy and gene therapy of oral cancer; Eradication of HIV-infected cells by suicide gene therapy

Luca Ermini
NORLUX Neuro-Oncology Laboratory, Luxembourg Institute of Health, Strassen, Luxembourg
Interests:

Cancer; Genomics; Evolutionary genetics; Bioinformatics; Computational biology

Marco Falasca
Curtin Health Innovation Research Institute, Curtin University, Perth, Australia
Interests:

Cell signalling; Lipid metabolism

Ana Faustino
Department of Zootechny, Universidade de Évora, Évora, Portugal
Interests:

Prostate cancer; Tumor

Gianluca Franceschini
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University, Rome, Italy
Interests:

Breast cancer; Breast surgery; Oncoplastic surgery; Mastectomy; Breast reconstruction; Breast cancer treatment

Pierfrancesco Franco
Department of Translational Medicine, University of Eastern Piedmont, and University Hospital "Maggiore della Carità", Novara, Italy
Interests:

Radiation and clinical oncology; Head and neck gastrointestinal breast tumors

Liwu Fu
Department of Experimental Research (Cancer Institute), Cancer Center, Sun Yat-sen University, Guangzhou, China
Interests:

Multidrug resistance; Tyrosine kinase inhibitor; ABC transporters; Exosomes; Cancer; Cancer stem cells

Profile:

Li-wu Fu, Ph.D., Professor, Doctoral Supervisor. Prof. Fu obtained his PhD in the field of Cancer Pharmacology from the Sun Yat-sen University and carried out his doctoral research in South Carolina Medical University from 1999 to 2001.

Prof. Fu’s field of expertise includes anticancer drug pharmacology, molecular mechanism of anticancer drugs and individual cancer chemotherapy. In recent years, he mainly focused on the study of molecular mechanism of anti-cancer drugs, drug resistance of cancer cells (especially multidrug resistance), the innate resistance of cancer stem cells and the individual cancer chemotherapy. For the excellent work in the research of “Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells”, Prof. Fu’s team gained the first prize of “Chinese Anti-Cancer Association (CACA) Science and Technology Award” (Ranked first) and the second prize of “Institute of Higher Education Outstanding Scientific Research Achievements Award” (Natural Science Award) in 2011.

As the leader of the research group, he has won the provincial and ministerial level scientific and technological awards for several times, including the “Outstanding young scientific and technological talents award from Ministry of Health”, the “Servier outstanding young workers Pharmacology Award” and the “Ding Ying Science Award” in 2011.

Prof. Fu has presided over and successfully completed more than 40 key research projects on national, provincial and ministerial scale and horizontal fund projects.

More than 200 research papers have been published and up to 100 papers have been published in high-quality SCI journals, including Cancer Res (6 articles), Oncotarget, Mol Med, Cell Cycle, Eur J Cancer, Mol Cancer Ther, Birth J Parmacol, Biochem Pharmacol , Mol Pharmacol etc. and 10 invention patents have been attained.

Niccola Funel
Department of Translational Research on New Technologies in Medicine and Surgery, Università di Pisa, Pisa, Italy
Interests:

Cancer biology; Cell culture; PCR; Primary cell culture; Immunohistochemistry

Jean Gabert
Department of Biology, Aix-Marseille University, Aix-en-Provence and Marseille, France
Interests:

Leukemia; CML; Hematologic diseases

Martha Patricia Gallegos-Arreola
División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico
Interests:

Cancer research; Gene; Genetics; in silico; Machine learning; Molecular biology

Dirk Geerts
Amsterdam UMC - University of Amsterdam, Amsterdam, Netherlands
Interests:

Oncology; Gene therapy; Cell therapy; Cancer research; Genomics; Transcriptomics

Profile:

Team Leader Cell Therapy at the Amsterdam UMC.

Dr. Geerts currently works as Team Leader Cell Therapy at the AmsterdamUMC. He is in charge of the CAR-T programs for treating cancer patients with immune cell therapy. Dirk did academic research in Gene and Cell Therapy in Cancer and Cardiovascular Disease. He is further actively involved in Cell Biology and Genetics with many different groups worldwide.

Francesca Giordano
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata, Italy
Interests:

Natural product; Cancer; Oxidative stress biomarkers; Modulatory action of nuclear receptors; Adipokines in the development and progression of breast cancer

Profile:

Associate Professor at the Department of Pharmacy, Health and Nutritional Sciences, University of Calabria.

Zhaohui Gong
Medical School, Ningbo University, Ningbo, China
Interests:

Cancer biomarker and diganosis; Noncoding RNA and cancer

Carmen Guerra
National Center for Oncological Research, Madrid, Spain
Interests:

Ras oncogenes; Pancreatic cancer; Pancreatitis; Rasopathies; Mouse models

Qinghua Guo
Peking University Sixth Hospital, Beijing, China
Interests:

Craniocerebral tumor; Glioma

Ken H Young
1. Department of Pathology, Duke University School of Medicine, Durham, NC, USA
2. Duke Cancer Institute, Durham, NC, USA
Interests:

Lymphoma; Biomarker; Molecular and genetic profiling

Profile:

Director of Hematopathology Division, Department of Pathology, Duke University School of Medicine
Vice Chair of Research in the Department of Pathology, Duke University School of Medicine 
Professor of Department of Pathology, Duke University School of Medicine 
Member of the Duke Cancer Institute  

Jens Claus Hahne
Institute of Cancer Research, London, UK
Interests:

Cancer biology; Cell biology; Tumour immunology; non-coding RNAs

Mohamed Hassan
1. Tulane University School of Medicine, New Orleans, LA, USA
2. Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, Strasbourg, France
Interests:

Apoptosis; Cancer research; Viral oncology; Infectious diseases

Wolfgang Hohenforst-Schmidt
Klinikum Bamberg, Erlangen, Germany
Interests:

Hybrid or interventions in lung disease; Drug-based tumor therapy

Nan Hu
Stempel College of Public Health, Florida International University, Miami, FL 33199, USA
Interests:

Pediatric cancers; COVID-19; Cardiovascular disease, Kidney disease, Neurological disorders, Radiology

Peter Huppert
Radiologisches Zentrum, Max Grundig Klinik, Bühlerhöhe, Germany
Interests:

Radiological imaging in oncology; Interventional radiology in oncology

Kiss István
Department of Public Health Medicine, Medical School, University of Pécs, Pécs, Hungary
Interests:

Molecular epidemiology of cancer; Individual susceptibility to cancer; Other chronic diseases – interactions between environmental and genetic factors in carcinogenesis

Weilin Jin
Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, China
Interests:

Translational neuroscience; Neurodevelopment; Axon regeneration; Gliomagenesis; Epigenetics

Kalevi Kairemo
Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interests:

Radionuclide imaging; Nuclear oncology; Early response assessment; Radionuclide therapies; Dosimetry; Dose planning; PET

Mohamed Kamal
USC Michelson Center Convergent Science Institute in Cancer, Los Angeles, CA, USA
Interests:

Cancer; Metastasis; Cancer stem cells; Circulating tumor cells; Liquid biopsy; Biomarker; Prognosis

Special Issue and Columns in AccScience journals
Mohammad Amjad Kamal
1. Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia 
2. Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Birulia, Savar, Dhaka, Bangladesh 
3. Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India 
4. Novel Global Community Educational Foundation, Hebersham, Australia
Interests:

Enzymoics; Neurobiology; Nanotechnology

Dionyssios Katsaros
Department of Surgical Sciences, Gynecologic Oncology, Città della Salute and S Anna Hospital, University of Turin, Turin, Italy
Interests:

Molecular oncology; Tumor markers; Cancer biomarkers; Gynecologic oncology; Clinical trials; Translational research

Ilya Klabukov
National Medical Research Radiological Center, Obninsk, Russia
Interests:

Regenerative medicine; Radiobiology; Tissue engineering; Cell technologies; Quantitative human physiology

Koji Komori
Department of Gastroenterological Surgery, Aichi Cancer Center, Nagoya, Japan
Interests:

Colorectal cancer; Colon cancer; Colorectal surgery; Gastrointestinal surgery; Abdominal surgery; Cancer surgery

Małgorzata Anna Krzystek-Korpacka
Department of Medical Biochemistry, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
Interests:

Cancer; Inflammation; Cancer biomarkers; Cancer diagnostics; Tumor biology; Gene expression; Tumor angiogenesis; Tumor markers; Molecular oncology 

Omer Kucuk
Emory University School of Medicine, Atlanta, GA, USA
Interests:

Cancer; Nutrition; Prevention; Genistein; Lycopene

Rahul Kumar
Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Interests:

Mitochondrial UPR; Cancer stem/progenitor cells; Prostate cancer; lncRNA; Genomic instability

Jong-Young Kwak
Department of Pharmacology & Immune Network Pioneer Research Center, Ajou University School of Medicine, Suwon, South Korea
Interests:

Bioprinting; Application of 3D hybrid NFS-based immune-network chip to several disease models; Lymphoma; Melanoma; Colon cancer; Inflammatory diseases

Seok-geun Lee
Department of Biomedical Science and Technology, Kyung Hee Univerisity, Seoul, South Korea
Interests:

Molecular genetics; Cancer biology; Cancer pharmacology; Bioactive phytochemicals

Sukmook Lee
Department of Biopharmaceutical Chemistry, School of Applied Chemistry, Kookmin University, Seoul, South Korea
Interests:

Nanobody; Antibody discovery and development; Bispecific antibody; Antibody drug conjugate; Neutralizing antibody; Bifunctional antibody repeats for potent and broad neutralization of SARS-CoV-2 variants

James Leigh
Asbestos and Dust Diseases Research Institute, University of Sydney, Sydney, Australia
Interests:

Lung cancer; Smoke

Robert Leonard
Oncology Department, Imperial College NHS Trust, London, UK
Interests:

Management of breast cancer; Metastasis; Cancer biomarkers; Cancer diagnostics; Molecular oncology; Tumors; Cancer

Zhipin Liang
School of Medicine, LSU Health Sciences Center, New Orleans, LA, USA
Interests:

MicroRNA; CRISPR

Terry Lichtor
Department of Neurological Surgery, Rush University Medical Center, Chicago, USA
Interests:

Alzheimer's disease; Brain tumors; Imaging; Immunotherapy; Medical neurosciences; Neurobiology; Spine surgery; Thyroid

Mikael S. Lindström
Karolinska Institutet, Stockholm, Sweden
Interests:

Cancer; Glioma; mdm2; Nucleolus; p53; Ribosomal protein

Yifei Liu
Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China
Interests:

Lung cancer; Tumor immunity

Yanqing Liu
Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA
Interests:

p53; Ferroptosis; Cancer

Profile:

Dr. Yanqing Liu is affiliated with the Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. His research interests focus on p53, Ferroptosis and Cancer.

Jose Manuel Lopes
Falcuty of Medicine, IPATIMUP, I3S, Centro Hospitalar Universitário São João, Porto, Portugal
Interests:

Biopathology; Oncobiology and anatomic pathology

Domenica Mangieri
Department of Clinical and Experimental Medicine, University of Foggia Medical School, Foggia, Italy
Interests:

Role of angiogenesis in tumor dissemination; Mechanisms underlying the growth and progression of carcinomas and sarcomas of soft connective tissues

Special Issue and Columns in AccScience journals
Francesco Marampon
Radiotherapy, Sapienza University of Rome, Roma, Italy
Interests:

Oncogenes; Radiotherapy; Prostate cancer; Cancer biology; Oncology; Cancer stem cells; Apoptosis; Radiation oncology; Cancer cells

Jose Juan Garcia Marin
Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain
Interests:

Hepatology; Pathophysiology; Pharmacology; Chemoresistance; Cancer

Cioce Mario
Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy
Interests:

Cancer biology; Cancer biomarkers; Cancer cell biology; Molecular oncology; Tumor microenvironment; Experimental oncology; Translational medicine; Cancer metabolism

Elena Mariotto
Pediatric Research Institute, Padova, Italy
Interests:

High-Throughput Screening (HTS); Drug screening; Precision medicine; Pediatric tumors; Brain tumors

Athina Markou
Department of Chemistry, National and Kapodistrian University of Athens, Athens, Greece
Interests:

Metastasis; Circulating tumor cells; Breast cancer; Methylation; Cancer biomarkers; Cancer diagnostics

Conti Matteo
Public Health Department, Azienda Unità Sanitaria Locale Imola, Bologna, Italy
Interests:

Cancer cells; Cancer biology

Stuart Maudsley
Receptor Biology Lab, Department of Biomedical Sciences, University of Antwerp, Antwerpen, Belgium
Interests:

G protein-coupled receptor; Aging; Proteomics; Bioinformatics; Therapeutics; Diabetes; Cancer; Artificial intelligence

Kefah Mokbel
The London Breast Institute, The Princess Grace Hospital, London, UK
Interests:

Breast surgery; Breast cancer; Oncoplastic breast surgery; Breast reconstruction; Sentinel node biopsy

Maria Beatrice Morelli
School of Pharmacy, University of Camerino, Camerino, Italy
Interests:

Cancer; Chemotherapy; Glioma; Stem cell; Ion channel; Signal transduction; Inflammation

Hamid Morjani
Faculty of Pharmacy, University of Reims Champagne-Ardenne, Reims, France
Interests:

Cancer biology; Cell signaling; Proteins; Transfection; Molecular biology; Gene expression

Profile:

Dr. Hamid Morjani is affiliated with the Faculty of Pharmacy, University of Reims Champagne-Ardenne, Reims, France. His research interests focus on Cancer biology, Cell signaling, Proteins, Transfection, Molecular biology and Gene expression.

Moe Muhith
Department of Medicine, Royal Marsden Hospital, London, UK
Interests:

Clinical immunology; Medical oncology; Infectious diseases

Subhadip Mukhopadhyay
Grossman School of Medicine, New York University, New York, NY, USA
Interests:

Apoptosis; Cancer therapy; Cancer biology; Autophagy; Cell death; Clinical trials; Pathology; Cancer biomarkers

David G. Mutch
Washington University School of Medicine in St. Louis, St Louis, MO, USA
Interests:

Endometrial cancer

Nicolas Orsi
School of Medicine, University of Leeds, Leeds, UK
Interests:

Reproductive biology; Oocytes/preimplantation embryos; Cytokines; Endometrial receptivity; Ovarian physiology; Endometrial cancer; Ovarian cancer; Digital pathology; Computer-aided diagnostics

Atsushi Otsuka
Department of Dermatology, Kindai University Faculty of Medicine, Osaka, Japan
Interests:

Melanoma; Atopic dermatitis; Allergy 

Prashanta Kumar Panda
Division of Pulmonary & Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
Interests:

Autophagy; Mitophagy; Apoptosis; Cancer; Metabolism; Neuroscience; Neutrophil biology

Gianpaolo Papaccio
Department of Experimental Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Via Armanni, 5, Naples, Italy
Interests:

Stem cells; Cancer stem cells; Cancer stem cells identification and eradication; Bone; Remodeling; Sarcomas; Adipose stem cells; Differentiation; Head and neck cancer

Pier Paolo Piccaluga
1. Biobank of Research, IRCCS Azienda Ospedaliera-Universitaria di Bologna Policlinico di S. Orsola, Bologna, Italy; 
2. Department of Medical and Surgical Sciences, Alma Mater Studiorum Università di Bologna, Bologna, Italy
Interests:

Leukemia; Lymphoma; Targeted therapy; Molecular diagnostics; High throughput genomics; Transcriptomics; Digital pathology

Special Issue and Columns in AccScience journals
Profile:

Associate Professor of Pathology & Executive Physician, Bologna University, S. Orsola Malpighi Hospital, Bologna, Italy

Adjunct Professor of Hematology and Pathology at Jomo Kenyatta University of Agricolture and Technology, Nairobi, Kenya

Member of the Scientific Committee, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy

National Academic Qualification as Full Professor of Pathology

Associate Editor for the American Journal of Blood Research, Modern Chemotherapy, World Journal of Hematology, Frontiers in Molecular Biosciences, Helyon.

Member of the SIE, SIES, ASH, AACR, SIAPEC/IAP, EHA, ELN/EWALL, FIL

Felisbina Luisa Pereira Guedes Queiroga
Department of the Veterinary Sciences, The University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
Interests:

Biochemistry; Genetics and molecular biology; Clinical pathology; Medicine; Oncology; Veterinary

Maria Gabriela Raso
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interests:

Pathology; Research; Pathology; Breast carcinoma; Lung cancer; Mouse models

Upasana Ray
University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interests:

Cancer therapeutics; Targeted therapy; Cancer metabolism; Cellular and molecular biology

Erle Robertson
Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA, USA
Interests:

Oncogenic viruses; Microbiome and cancer

Giovanni Rosti
Oncology Unit, Medical Oncology, Treviso Hospital, Treviso, Italy
Interests:

Testicular tumors and supportive care in cancer

Ravi P. Sahu
Pharmacology & Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH, USA
Interests:

Pro-oxidative stressors and lipid mediators; Cancer pharmacology and chemoprevention; Anticancer therapeutics and immunomodulation; Photobiology and environmental factors; Cellular signaling pathways in tumor resistance mechanisms; Antitumor immune responses

Andrea Sambri
Orthopaedic Oncology and Trauma Surgeon, IRCCS University Hospital Sant’Orsola, Bologna, Italy
Interests:

Antibiotic-loaded cement; Bone tumors; Hip arthroplasty; Knee; Prostheses and implants; Sarcoma; Soft tissue sarcoma

Ahmad Sayasneh
Guy's and St Thomas' NHS Trust, London, UK
Interests:

Gynecologic oncology; Reproductive endocrinology; Endometriosis; Medicine; Gynecology

Bruna Scaggiante
Department of Life Sciences, University of Trieste, Trieste, Italy
Interests:

Cancer biomarkers; Epigenetic; Epigenetic sequencing; Exosome; Extracellular vesicle; Liquid biopsy

Profile:

Dr. Bruna Scaggiante is affiliated with Department of Life Sciences, University of Trieste, Trieste, Italy. Her research interests focus on Cancer biomarkers, Epigenetic, Epigenetic sequencing, Exosome, Extracellular vesicle and Liquid biopsy.

Axel Schonthal
Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Interests:

Malignant brain tumors; Cancer cells

Gautam Sethi
Department of Pharmacology, Yong Loo Lin School of Medicine, Queenstown, Singapore
Interests:

Cancer; Inflammation; Transcription factors; Vitamin; Apoptosis

Profile:

Associate Professor at the Yong Loo Lin School of Medicine, Queenstown, Singapore.
Dr. Sethi is the editorial board member of 11 different international journals.

AVAILABILITY

  • Collaborative projects
  • Industry Projects
  • Masters Research or PhD student supervision
  • Join a web conference as a panellist or speaker
  • Mentoring (long-term)
  • Media enquiries
  • Mentoring (short-term)

 

Vishal Shelat
Tan Tock Seng Hospital, Novena, Singapore
Interests:

Hepato-pancreatico-biliary surgery; Oncology; Gastroenterology

Jingdong Shi
Beijing Tiantan Hospital, Beijing, China
Interests:

Hepatobiliary surgery related tumor diagnosis and treatment

Xiaoyu Shi
The First Affiliated Hospital of Hebei North University, Zhangjiakou, China
Interests:

Clinical study of malignant tumor

Alexander Shtil
Blokhin National Medical Research Center of Oncology, Ministry of Health, Moscow, Russian Federation
Interests:

Mechanisms of drug resistance in tumor cells; Mechanisms of tumor cell death induced by extracellular stimuli, in particular, by chemotherapeutic drugs

Hifzur R Siddique
Aligarh Muslim University, Aligarh, India
Interests:

Stem cells; Cancer stem cells; Non-coding RNAs; Therapy resistance cancer and Transgenesis

Cynthia Simbulan-Rosenthal
Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, DC, USA
Interests:

Cancer research; Molecular biology; Cell biology; Apoptosis; Cell proliferation

Zheng Song
Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
Interests:

Lymphoma research

Maria Patrizia Stoppelli
Department of Biomedical Sciences (DSB),  National Research Council, Via Pietro Castellino, Napoli, Italy
Interests:

Cancer research; Cancer biology; Cell adhesion; Extracellular matrix; Tumors

Senthilkumar Subramanian
School of Medicine College of Medicine and Health Science Jigjiga University, Jijiga, Ethiopia
Interests:

Biochemical toxicology; Physiology; Metabolic disorders and immunology; Herbal medicine and cancer biology

Myron Szewczuk
Department of Biomedical and Molecular Sciences, Queen's University, Ontario, Canada
Interests:

Alternate therapeutic treatment of cancer

Joseph R. Testa
Human Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA
Interests:

Molecular biology of mesothelioma; Role of AKT in oncogenesis

Soraya L. Valles
Department of Physiology, School of Medicine, University of Valencia, Valencia, Spain
Interests:

Alzheimer's disease; Astrocytes; Brain; Cell signalling; Gliomas; Neuroblastoma; Neurodegeneration; Neurodevelopment

Maria Teresa Vietri
Unity of Clinical and Molecular Pathology, Azienda Ospedaliera Universitaria (AOU), Naples, Italy
Interests:

Hereditary breast and ovarian cancer; Hereditary cancer syndrome; Cardiovascular diseases; Metabolic and endocrine diseases

Qiujun Wang
Department of General Practice, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Interests:

Bone marrow mesenchymal stem cells

Yanjun Wei
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interests:

Identification of the cryptic novel proteins that play an important function in human cancer; Computational-based CRISPR screen / NLS library design; AI-based big data platform

Norman R. Williams
Division of Surgery & Interventional Science, University College London, London, UK
Interests:

Breast cancer; Breast conservative therapy; Cardiovascular disease; Comparative studies; Data science; Fetal growth; Nutrition

Bingli Wu
Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, China
Interests:

Esophageal cancer; Brain tumor; Bioinformatics; Protein-protein interaction network; Molecular biology

Profile:

Dr. Bingli Wu is affiliated with Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, China . His research interests focus on Esophageal cancer, Brain tumor, Bioinformatics, Protein-protein interaction network and Molecular biology.

Guifang Xu
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
Interests:

Gastric cancer; Inflammatory bowel disease 

Yan Xu
Department of Endocrinology, Peking University Shougang Hospital, Beijing, China
Interests:

Diabetes; Vitamin D and cancer

Jun Xu
Department of Neurology, Beijing Tiantan Hospital, Beijing, China
Interests:

Alzheimer's disease; Leukoencephalopathy; Cognitive impairment; Cognitive aging

Masayoshi Yamaguchi
University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI, USA
Interests:

Regucalcin; RGPR-p117 transcription factor; Calcium signaling and bone; Cancer biology; Nutraceuticals

Qin Yan
The Department of Pathology, Yale School of Medicine, New Haven, CT, USA
Interests:

Epigenetic regulation of cancer immunity

Huike Yang
School of Basic Medical Sciences, Harbin Medical University, Harbin, China
Interests:

Mechanism of cancer metastasis

Bin Yi
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, USA
Interests:

Cancer chemoprevention; Immunotherapy; Exosome; Cancer metastasis; MicroRNAs

Chunyang Zhang
Department of Thoracic Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
Interests:

Lung cancer; Esophageal cancer; Thymic epithelial tumor

Meiling Zhang
The Department of Pathology, Yale School of Medicine, New Haven, CT, USA
Interests:

Tumor Epigenetics; Immunotherapy

Xinyuan Zhao
School of Public Health, Nantong University, Nantong, China
Interests:

Lung cancer

Yunfeng Zhao
Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center - Shreveport, Shreveport, LA, USA
Interests:

Cancer metabolism; Redox biology; Toxicology; Carcinogenesis

Shaoquan Zheng
Breast Disease Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Interests:

Breast cancer

Xingang Zhou
Department of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Interests:

Oncologic pathology; Liver tumors; CNS tumors

Massimo Zollo
Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli Federico II, Naples, Italy
Interests:

Cancer genetics

Youth Editorial Board Members
Tariq A. Bhat
Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Interests:

Tumor immunology and immunotherapy; CAR-T cell therapy; Cancer immunometabolism; Cancer metastasis and therapeutics; Genitourinary malignancies (like prostate cancer); Lung cancer; Pancreatic cancer

Yiyang Chen
Department of Hepatobiliary and Pancreatic Surgery, Shenzhen Xinhua Hospital, Shenzhen, China
Interests:

Surgical oncology; Liver cancer; Pancreatic cancer; Gastrointestinal tract related tumors

Xufeng Chen
Department of Pathology, New York University, New York, NY, USA
Interests:

Cancer; Leukemia; Acute myeloid leukemia; Hematopoiesis

Xinpei Deng
Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
Interests:

Oncology; Breast cancer; Bioinformatics; Radiomics; Data analysis

Angelo Corso Faini
Department of Medical Sciences, University of Turin, Torino, Italy
Interests:

Cancer genetics; Natural killer cells; Multiple myeloma

Alessandra Ferraresi
Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale, via Solaroli 17, Novara, Italy
Interests:

Cancer; Autophagy; Metabolism; Nutraceuticals; Nanomedicine

Vincenzo Fiorentino
Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, University of Messina, Messina, Italy
Interests:

Uropathology; Thyroid pathology; Cytopathology; Molecular pathology; Hematopathology

Ludovica Pepe
Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy
Interests:

Uropathology; Thyroid pathology; Cytopathology; Molecular pathology; Skin pathology

Zhuo Wang
College of Health and Life Sciences, Aston University, Birmingham, UK
Interests:

Fibrotic diseases; Cancer; Pathological angiogenesis

Jindong Xie
Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
Interests:

Molecular science diagnosis; Multi-omics of oncology

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. AccScience Publishing remains neutral with regard to any jurisdictional claims.
Back to top
Tumor Discovery, Electronic ISSN: 2810-9775 Print ISSN: 3060-8597, Published by AccScience Publishing